3Yoshimura M,Yasuec H,Okamura K,et al.Different secretion pattern of atrial natriuretic peptide and brian natriuretic peptide in patients with congestive heaet failure[J].Circulation,1993,87(2):464.
4Dickstein K.Natriuretic peptides in detection of heart failure[J].Lancet,1997,351(9095):3.
5Luchner A,Stevens TL Borgeson DD,et al.Differntial atrial and ventricular expression of myocatdial BNP during evolution of heart failure[J].An J Physiol,1998,274(5):H1684.
3Bhatia V, Nayyar P,Dhindsa S. Brain natriuretic pepide in diagnosis and treatment of heart failure. J Postgrad Med, 2003,49: 182-185.
4Villacorta H,Duarte A,Duarte NM,et al. The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq Bras Cardiol, 2002,79 : 569-572.
5Logeart D, Saudubray C. Beyne P, et al. Comparative value of doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol, 2002,40: 1794-1800.
6Maisel A. B-type natriuretic peptide levels:diagnostic and therapeutic potential. Cardiovasc Toxicol, 2001,1:159-164.
7Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002,347:161-167.
8Maisel AS, McCord J, Nowak RM. et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol, 2003,41:2010-
9Yamamoto K,Burnett J,Bermudez EA,et al. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail, 2000,6 : 194-200.
10Cheung BM,Kumana CR.Natriuretic peptides-relenance in cardiovascular disease[J].JAMA,1998,280:1983.
